206 related articles for article (PubMed ID: 22333133)
1. Diet supplementation with green tea extract epigallocatechin gallate prevents progression to glucose intolerance in db/db mice.
Ortsäter H; Grankvist N; Wolfram S; Kuehn N; Sjöholm A
Nutr Metab (Lond); 2012 Feb; 9():11. PubMed ID: 22333133
[TBL] [Abstract][Full Text] [Related]
2. Epigallocatechin gallate supplementation alleviates diabetes in rodents.
Wolfram S; Raederstorff D; Preller M; Wang Y; Teixeira SR; Riegger C; Weber P
J Nutr; 2006 Oct; 136(10):2512-8. PubMed ID: 16988119
[TBL] [Abstract][Full Text] [Related]
3. Decaffeinated green tea extract rich in epigallocatechin-3-gallate prevents fatty liver disease by increased activities of mitochondrial respiratory chain complexes in diet-induced obesity mice.
Santamarina AB; Carvalho-Silva M; Gomes LM; Okuda MH; Santana AA; Streck EL; Seelaender M; do Nascimento CM; Ribeiro EB; Lira FS; Oyama LM
J Nutr Biochem; 2015 Nov; 26(11):1348-56. PubMed ID: 26300331
[TBL] [Abstract][Full Text] [Related]
4. Epigallocatechin gallate reduces vascular inflammation in db/db mice possibly through an NF-κB-mediated mechanism.
Babu PV; Si H; Liu D
Mol Nutr Food Res; 2012 Sep; 56(9):1424-32. PubMed ID: 22753231
[TBL] [Abstract][Full Text] [Related]
5. Dietary Epigallocatechin-3-Gallate Alters the Gut Microbiota of Obese Diabetic
Park JM; Shin Y; Kim SH; Jin M; Choi JJ
J Med Food; 2020 Oct; 23(10):1033-1042. PubMed ID: 33054538
[TBL] [Abstract][Full Text] [Related]
6. Metallothionein 1 negatively regulates glucose-stimulated insulin secretion and is differentially expressed in conditions of beta cell compensation and failure in mice and humans.
Bensellam M; Shi YC; Chan JY; Laybutt DR; Chae H; Abou-Samra M; Pappas EG; Thomas HE; Gilon P; Jonas JC
Diabetologia; 2019 Dec; 62(12):2273-2286. PubMed ID: 31624901
[TBL] [Abstract][Full Text] [Related]
7. Green tea epigallocatechin 3-gallate alleviates hyperglycemia and reduces advanced glycation end products via nrf2 pathway in mice with high fat diet-induced obesity.
Sampath C; Rashid MR; Sang S; Ahmedna M
Biomed Pharmacother; 2017 Mar; 87():73-81. PubMed ID: 28040599
[TBL] [Abstract][Full Text] [Related]
8. Green tea, black tea, and epigallocatechin modify body composition, improve glucose tolerance, and differentially alter metabolic gene expression in rats fed a high-fat diet.
Chen N; Bezzina R; Hinch E; Lewandowski PA; Cameron-Smith D; Mathai ML; Jois M; Sinclair AJ; Begg DP; Wark JD; Weisinger HS; Weisinger RS
Nutr Res; 2009 Nov; 29(11):784-93. PubMed ID: 19932867
[TBL] [Abstract][Full Text] [Related]
9. Epigallocatechin-3-gallate (EGCG) activates AMPK through the inhibition of glutamate dehydrogenase in muscle and pancreatic ß-cells: A potential beneficial effect in the pre-diabetic state?
Pournourmohammadi S; Grimaldi M; Stridh MH; Lavallard V; Waagepetersen HS; Wollheim CB; Maechler P
Int J Biochem Cell Biol; 2017 Jul; 88():220-225. PubMed ID: 28137482
[TBL] [Abstract][Full Text] [Related]
10. Oral green tea catechins transiently lower plasma glucose concentrations in female db/db mice.
Wein S; Schrader E; Rimbach G; Wolffram S
J Med Food; 2013 Apr; 16(4):312-7. PubMed ID: 23514230
[TBL] [Abstract][Full Text] [Related]
11. [In vivo study of the renoprotective effects of EGCG in diabetic db/db mice].
Yang X; Li Y; Feng C; Guo L; Jin H
Zhonghua Yi Xue Za Zhi; 2016 May; 96(17):1330-5. PubMed ID: 27180749
[TBL] [Abstract][Full Text] [Related]
12. The protective effect of epigallocatechin 3-gallate on mouse pancreatic islets via the Nrf2 pathway.
Wada Y; Takata A; Ikemoto T; Morine Y; Imura S; Iwahashi S; Saito Y; Shimada M
Surg Today; 2019 Jun; 49(6):536-545. PubMed ID: 30730004
[TBL] [Abstract][Full Text] [Related]
13. Decaffeinated green tea extract rich in epigallocatechin-3-gallate improves insulin resistance and metabolic profiles in normolipidic diet--but not high-fat diet-fed mice.
Santana A; Santamarina A; Souza G; Mennitti L; Okuda M; Venancio D; Seelaender M; do Nascimento CO; Ribeiro E; Lira F; Oyama L
J Nutr Biochem; 2015 Sep; 26(9):893-902. PubMed ID: 26048201
[TBL] [Abstract][Full Text] [Related]
14. Green tea decoction improves glucose tolerance and reduces weight gain of rats fed normal and high-fat diet.
Snoussi C; Ducroc R; Hamdaoui MH; Dhaouadi K; Abaidi H; Cluzeaud F; Nazaret C; Le Gall M; Bado A
J Nutr Biochem; 2014 May; 25(5):557-64. PubMed ID: 24656388
[TBL] [Abstract][Full Text] [Related]
15. Dietary pretreatment with green tea polyphenol, (-)-epigallocatechin-3-gallate reduces the bioavailability and hepatotoxicity of subsequent oral bolus doses of (-)-epigallocatechin-3-gallate.
James KD; Forester SC; Lambert JD
Food Chem Toxicol; 2015 Feb; 76():103-8. PubMed ID: 25528115
[TBL] [Abstract][Full Text] [Related]
16. Epigallocatechin-3-gallate Attenuates Renal Damage by Suppressing Oxidative Stress in Diabetic db/db Mice.
Yang XH; Pan Y; Zhan XL; Zhang BL; Guo LL; Jin HM
Oxid Med Cell Longev; 2016; 2016():2968462. PubMed ID: 27698952
[TBL] [Abstract][Full Text] [Related]
17. TEAVIGO (epigallocatechin gallate) supplementation prevents obesity in rodents by reducing adipose tissue mass.
Wolfram S; Raederstorff D; Wang Y; Teixeira SR; Elste V; Weber P
Ann Nutr Metab; 2005; 49(1):54-63. PubMed ID: 15735368
[TBL] [Abstract][Full Text] [Related]
18. Effect of green tea on blood glucose levels and serum proteomic patterns in diabetic (db/db) mice and on glucose metabolism in healthy humans.
Tsuneki H; Ishizuka M; Terasawa M; Wu JB; Sasaoka T; Kimura I
BMC Pharmacol; 2004 Aug; 4():18. PubMed ID: 15331020
[TBL] [Abstract][Full Text] [Related]
19. Green tea polyphenol epigallocatechin-3-gallate ameliorates insulin resistance in non-alcoholic fatty liver disease mice.
Gan L; Meng ZJ; Xiong RB; Guo JQ; Lu XC; Zheng ZW; Deng YP; Luo BD; Zou F; Li H
Acta Pharmacol Sin; 2015 May; 36(5):597-605. PubMed ID: 25891086
[TBL] [Abstract][Full Text] [Related]
20. Acute effects of epigallocatechin gallate from green tea on oxidation and tissue incorporation of dietary lipids in mice fed a high-fat diet.
Friedrich M; Petzke KJ; Raederstorff D; Wolfram S; Klaus S
Int J Obes (Lond); 2012 May; 36(5):735-43. PubMed ID: 21750518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
